Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.34
OMI's Cash to Debt is ranked lower than
71% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. OMI: 0.34 )
Ranked among companies with meaningful Cash to Debt only.
OMI' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.08 Max: 1.06
Current: 0.34
0
1.06
Equity to Asset 0.36
OMI's Equity to Asset is ranked lower than
59% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. OMI: 0.36 )
Ranked among companies with meaningful Equity to Asset only.
OMI' s Equity to Asset Range Over the Past 10 Years
Min: 0.2  Med: 0.38 Max: 0.49
Current: 0.36
0.2
0.49
Interest Coverage 7.55
OMI's Interest Coverage is ranked lower than
55% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.35 vs. OMI: 7.55 )
Ranked among companies with meaningful Interest Coverage only.
OMI' s Interest Coverage Range Over the Past 10 Years
Min: 6.23  Med: 12.49 Max: 15.45
Current: 7.55
6.23
15.45
F-Score: 7
Z-Score: 5.27
M-Score: -2.53
WACC vs ROIC
7.51%
9.00%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 2.08
OMI's Operating margin (%) is ranked lower than
68% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.57 vs. OMI: 2.08 )
Ranked among companies with meaningful Operating margin (%) only.
OMI' s Operating margin (%) Range Over the Past 10 Years
Min: 1.69  Med: 2.20 Max: 2.5
Current: 2.08
1.69
2.5
Net-margin (%) 1.10
OMI's Net-margin (%) is ranked lower than
74% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.77 vs. OMI: 1.10 )
Ranked among companies with meaningful Net-margin (%) only.
OMI' s Net-margin (%) Range Over the Past 10 Years
Min: 0.7  Med: 1.22 Max: 1.36
Current: 1.1
0.7
1.36
ROE (%) 10.88
OMI's ROE (%) is ranked higher than
60% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.26 vs. OMI: 10.88 )
Ranked among companies with meaningful ROE (%) only.
OMI' s ROE (%) Range Over the Past 10 Years
Min: 6.54  Med: 12.03 Max: 14.35
Current: 10.88
6.54
14.35
ROA (%) 3.93
OMI's ROA (%) is ranked higher than
50% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.93 vs. OMI: 3.93 )
Ranked among companies with meaningful ROA (%) only.
OMI' s ROA (%) Range Over the Past 10 Years
Min: 2.63  Med: 5.07 Max: 6.2
Current: 3.93
2.63
6.2
ROC (Joel Greenblatt) (%) 22.12
OMI's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.71 vs. OMI: 22.12 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 16.75  Med: 24.78 Max: 30.56
Current: 22.12
16.75
30.56
Revenue Growth (3Y)(%) 3.50
OMI's Revenue Growth (3Y)(%) is ranked lower than
58% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. OMI: 3.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.6  Med: 4.20 Max: 13.5
Current: 3.5
-0.6
13.5
EBITDA Growth (3Y)(%) 4.50
OMI's EBITDA Growth (3Y)(%) is ranked lower than
58% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.70 vs. OMI: 4.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OMI' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -1.7  Med: 5.10 Max: 22.7
Current: 4.5
-1.7
22.7
EPS Growth (3Y)(%) -1.70
OMI's EPS Growth (3Y)(%) is ranked lower than
79% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.60 vs. OMI: -1.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -16.4  Med: 13.60 Max: 49.4
Current: -1.7
-16.4
49.4
» OMI's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-28)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

OMI Guru Trades in Q2 2015

Steven Cohen 800 sh (New)
Joel Greenblatt 38,139 sh (New)
Charles Brandes 15,190 sh (New)
Jim Simons 375,750 sh (+129.89%)
Barrow, Hanley, Mewhinney & Strauss 149,712 sh (+29.75%)
John Keeley 38,160 sh (+8.98%)
David Dreman 255,564 sh (+8.88%)
Paul Tudor Jones 27,400 sh (+1.48%)
Richard Pzena 1,087,551 sh (+0.94%)
Pioneer Investments 598,149 sh (+0.25%)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Mario Gabelli 193,650 sh (-4.91%)
Chuck Royce 1,475,150 sh (-7.47%)
» More
Q3 2015

OMI Guru Trades in Q3 2015

John Hussman 4,000 sh (New)
Joel Greenblatt 1,152,390 sh (+2921.55%)
Paul Tudor Jones 250,000 sh (+812.41%)
John Keeley 52,725 sh (+38.17%)
David Dreman 290,760 sh (+13.77%)
Pioneer Investments 599,460 sh (+0.22%)
Barrow, Hanley, Mewhinney & Strauss 149,712 sh (unchged)
Charles Brandes 15,190 sh (unchged)
Mario Gabelli 193,650 sh (unchged)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Steven Cohen Sold Out
Richard Pzena 1,037,426 sh (-4.61%)
Chuck Royce 1,372,150 sh (-6.98%)
Jim Simons 28,450 sh (-92.43%)
» More
Q4 2015

OMI Guru Trades in Q4 2015

Jim Simons 238,850 sh (+739.54%)
Barrow, Hanley, Mewhinney & Strauss 152,574 sh (+1.91%)
Charles Brandes 15,190 sh (unchged)
Mario Gabelli 193,650 sh (unchged)
Joel Greenblatt Sold Out
David Dreman Sold Out
John Hussman Sold Out
Vanguard Health Care Fund Sold Out
Pioneer Investments 598,633 sh (-0.14%)
Richard Pzena 1,029,003 sh (-0.81%)
John Keeley 48,225 sh (-8.53%)
Chuck Royce 1,226,150 sh (-10.64%)
Paul Tudor Jones 15,000 sh (-94.00%)
» More
Q1 2016

OMI Guru Trades in Q1 2016

David Dreman 217,050 sh (New)
Joel Greenblatt 64,655 sh (New)
Jim Simons 410,450 sh (+71.84%)
Paul Tudor Jones 22,733 sh (+51.55%)
Barrow, Hanley, Mewhinney & Strauss 158,857 sh (+4.12%)
Mario Gabelli 193,650 sh (unchged)
Charles Brandes Sold Out
Pioneer Investments 578,633 sh (-3.34%)
Chuck Royce 1,148,650 sh (-6.32%)
John Keeley 43,255 sh (-10.31%)
Richard Pzena 449,414 sh (-56.33%)
» More
» Details

Insider Trades

Latest Guru Trades with OMI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:NAS:PDCO, TSE:7459, NYSE:PBH, SZSE:002589, SHSE:600056 » details
Traded in other countries:6OM.Germany,
Owens & Minor Inc is a healthcare logistics company that connects the world of medical products to the point of care.

Owens & Minor Inc was founded in 1882 and incorporated in 1926 in Richmond, Virginia. The Company is a healthcare logistics company that connects the world of medical products to the point of care. It provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices in the United States and Europe. The Company on August 31, 2012, acquired the Movianto Group (Movianto), an established European healthcare third-party logistics provider. The Company's domestic segment includes all functions in the United States relating to Company's role as a healthcare services company providing distribution and logistics services to healthcare providers and manufacturers. The International segment consists of Movianto, Company's European third-party logistics service. The Company's competitors are Cardinal Health, Inc. and privately-held Medline, Inc. The Domestic segment had 43 distribution centers as well as office and warehouse space across the United States. The International segment leases18 and owns two logistics centers across 11 European countries. The Company provides distribution, outsourced resource management and/or consulting services to thousands of healthcare provider customers which include multi-facility networks of healthcare providers offering a broad spectrum of healthcare services to a particular market or markets (IHNs) as well as smaller, independent hospitals in the United States. The medical/surgical supply distribution industry is subject to regulation by federal, state and local government agencies.

Ratios

vs
industry
vs
history
P/E(ttm) 21.24
OMI's P/E(ttm) is ranked higher than
56% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.48 vs. OMI: 21.24 )
Ranked among companies with meaningful P/E(ttm) only.
OMI' s P/E(ttm) Range Over the Past 10 Years
Min: 13.55  Med: 19.83 Max: 36.19
Current: 21.24
13.55
36.19
Forward P/E 16.42
OMI's Forward P/E is ranked lower than
58% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.66 vs. OMI: 16.42 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.24
OMI's PE(NRI) is ranked higher than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.35 vs. OMI: 21.24 )
Ranked among companies with meaningful PE(NRI) only.
OMI' s PE(NRI) Range Over the Past 10 Years
Min: 13.47  Med: 19.52 Max: 35.63
Current: 21.24
13.47
35.63
Price/Owner Earnings (ttm) 22.83
OMI's Price/Owner Earnings (ttm) is ranked higher than
67% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.65 vs. OMI: 22.83 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
OMI' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 6  Med: 17.62 Max: 322.64
Current: 22.83
6
322.64
P/B 2.29
OMI's P/B is ranked lower than
52% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.23 vs. OMI: 2.29 )
Ranked among companies with meaningful P/B only.
OMI' s P/B Range Over the Past 10 Years
Min: 1.79  Med: 2.26 Max: 3.1
Current: 2.29
1.79
3.1
P/S 0.23
OMI's P/S is ranked higher than
82% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.84 vs. OMI: 0.23 )
Ranked among companies with meaningful P/S only.
OMI' s P/S Range Over the Past 10 Years
Min: 0.18  Med: 0.23 Max: 0.29
Current: 0.23
0.18
0.29
PFCF 20.06
OMI's PFCF is ranked lower than
55% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.10 vs. OMI: 20.06 )
Ranked among companies with meaningful PFCF only.
OMI' s PFCF Range Over the Past 10 Years
Min: 5.38  Med: 18.69 Max: 2771.25
Current: 20.06
5.38
2771.25
POCF 15.60
OMI's POCF is ranked higher than
50% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.69 vs. OMI: 15.60 )
Ranked among companies with meaningful POCF only.
OMI' s POCF Range Over the Past 10 Years
Min: 4.92  Med: 14.50 Max: 62.83
Current: 15.6
4.92
62.83
EV-to-EBIT 13.11
OMI's EV-to-EBIT is ranked higher than
64% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.35 vs. OMI: 13.11 )
Ranked among companies with meaningful EV-to-EBIT only.
OMI' s EV-to-EBIT Range Over the Past 10 Years
Min: 8  Med: 11.40 Max: 22.8
Current: 13.11
8
22.8
EV-to-EBITDA 10.10
OMI's EV-to-EBITDA is ranked higher than
65% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.87 vs. OMI: 10.10 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 9.50 Max: 16.4
Current: 10.1
7.1
16.4
PEG 9.68
OMI's PEG is ranked lower than
95% of the 21 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.83 vs. OMI: 9.68 )
Ranked among companies with meaningful PEG only.
OMI' s PEG Range Over the Past 10 Years
Min: 0.92  Med: 3.05 Max: 197.88
Current: 9.68
0.92
197.88
Shiller P/E 22.86
OMI's Shiller P/E is ranked higher than
76% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.60 vs. OMI: 22.86 )
Ranked among companies with meaningful Shiller P/E only.
OMI' s Shiller P/E Range Over the Past 10 Years
Min: 18.5  Med: 23.83 Max: 34.4
Current: 22.86
18.5
34.4
Current Ratio 1.88
OMI's Current Ratio is ranked higher than
64% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.65 vs. OMI: 1.88 )
Ranked among companies with meaningful Current Ratio only.
OMI' s Current Ratio Range Over the Past 10 Years
Min: 1.55  Med: 1.83 Max: 2.17
Current: 1.88
1.55
2.17
Quick Ratio 1.01
OMI's Quick Ratio is ranked lower than
53% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.11 vs. OMI: 1.01 )
Ranked among companies with meaningful Quick Ratio only.
OMI' s Quick Ratio Range Over the Past 10 Years
Min: 0.6  Med: 0.93 Max: 1.17
Current: 1.01
0.6
1.17
Days Inventory 38.44
OMI's Days Inventory is ranked higher than
60% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 49.79 vs. OMI: 38.44 )
Ranked among companies with meaningful Days Inventory only.
OMI' s Days Inventory Range Over the Past 10 Years
Min: 34.46  Med: 35.87 Max: 40.9
Current: 38.44
34.46
40.9
Days Sales Outstanding 22.85
OMI's Days Sales Outstanding is ranked higher than
82% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.08 vs. OMI: 22.85 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.19  Med: 22.84 Max: 35.56
Current: 22.85
21.19
35.56
Days Payable 32.11
OMI's Days Payable is ranked lower than
85% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 69.49 vs. OMI: 32.11 )
Ranked among companies with meaningful Days Payable only.
OMI' s Days Payable Range Over the Past 10 Years
Min: 26.53  Med: 27.86 Max: 40.11
Current: 32.11
26.53
40.11

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.76
OMI's Dividend Yield is ranked higher than
75% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.63 vs. OMI: 2.76 )
Ranked among companies with meaningful Dividend Yield only.
OMI' s Dividend Yield Range Over the Past 10 Years
Min: 1.47  Med: 2.37 Max: 3.19
Current: 2.76
1.47
3.19
Dividend Payout 0.58
OMI's Dividend Payout is ranked lower than
65% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.30 vs. OMI: 0.58 )
Ranked among companies with meaningful Dividend Payout only.
OMI' s Dividend Payout Range Over the Past 10 Years
Min: 0.21  Med: 0.35 Max: 2.08
Current: 0.58
0.21
2.08
Dividend Growth (3y) 4.70
OMI's Dividend Growth (3y) is ranked lower than
76% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.20 vs. OMI: 4.70 )
Ranked among companies with meaningful Dividend Growth (3y) only.
OMI' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 4.7  Med: 12.80 Max: 19.7
Current: 4.7
4.7
19.7
Forward Dividend Yield 2.78
OMI's Forward Dividend Yield is ranked higher than
74% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.82 vs. OMI: 2.78 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 3.96
OMI's Yield on cost (5-Year) is ranked lower than
54% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.04 vs. OMI: 3.96 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
OMI' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 2.11  Med: 3.40 Max: 4.58
Current: 3.96
2.11
4.58
3-Year Average Share Buyback Ratio 0.20
OMI's 3-Year Average Share Buyback Ratio is ranked higher than
68% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.80 vs. OMI: 0.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OMI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.5  Med: -1.10 Max: 0.2
Current: 0.2
-5.5
0.2

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 11.00
OMI's Price/Net Current Asset Value is ranked lower than
88% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.67 vs. OMI: 11.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
OMI' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 3.55  Med: 5.93 Max: 106.43
Current: 11
3.55
106.43
Price/Tangible Book 4.69
OMI's Price/Tangible Book is ranked lower than
75% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.39 vs. OMI: 4.69 )
Ranked among companies with meaningful Price/Tangible Book only.
OMI' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.72  Med: 4.48 Max: 184.21
Current: 4.69
2.72
184.21
Price/Projected FCF 1.48
OMI's Price/Projected FCF is ranked higher than
50% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. OMI: 1.48 )
Ranked among companies with meaningful Price/Projected FCF only.
OMI' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.84  Med: 1.36 Max: 2.7
Current: 1.48
0.84
2.7
Price/DCF (Earnings Based) 1.98
OMI's Price/DCF (Earnings Based) is ranked lower than
88% of the 8 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.57 vs. OMI: 1.98 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.01
OMI's Price/Median PS Value is ranked higher than
51% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. OMI: 1.01 )
Ranked among companies with meaningful Price/Median PS Value only.
OMI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.37  Med: 0.95 Max: 1.22
Current: 1.01
0.37
1.22
Price/Graham Number 2.11
OMI's Price/Graham Number is ranked lower than
62% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. OMI: 2.11 )
Ranked among companies with meaningful Price/Graham Number only.
OMI' s Price/Graham Number Range Over the Past 10 Years
Min: 1.36  Med: 1.91 Max: 15.44
Current: 2.11
1.36
15.44
Earnings Yield (Greenblatt) (%) 7.63
OMI's Earnings Yield (Greenblatt) (%) is ranked higher than
68% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. OMI: 7.63 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.4  Med: 8.80 Max: 12.4
Current: 7.63
4.4
12.4
Forward Rate of Return (Yacktman) (%) 5.82
OMI's Forward Rate of Return (Yacktman) (%) is ranked lower than
68% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. OMI: 5.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OMI' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 2.8  Med: 9.80 Max: 20
Current: 5.82
2.8
20

More Statistics

Revenue (TTM) (Mil) $9,838
EPS (TTM) $ 1.73
Beta1.01
Short Percentage of Float15.34%
52-Week Range $31.89 - 41.48
Shares Outstanding (Mil)62.79

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 9,991 10,141 10,371
EPS ($) 2.06 2.24 2.43
EPS without NRI ($) 2.06 2.24 2.43
EPS Growth Rate
(3Y to 5Y Estimate)
20.25%
» More Articles for OMI

Headlines

Articles On GuruFocus.com
Cardinal Health, Inc. (CAH) Dividend Stock Analysis Dec 17 2014 
AmerisourceBergen a Key Player in the Pharma Industry Dec 10 2014 
Guru-Held Stocks Near Historical Low P/S Oct 03 2014 
Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
Guru Held Stocks Trading Near Historical Low P/S Ratios Jul 18 2014 
Cardinal Health Inc. (CAH) Dividend Stock Analysis Jul 03 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S Jun 04 2014 
Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S May 28 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 20 2014 
Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S May 13 2014 

More From Other Websites
OWENS & MINOR INC/VA/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 11 2016
OWENS & MINOR INC/VA/ Financials May 11 2016
Trending Now: OMI May 09 2016
OWENS & MINOR INC/VA/ Files SEC form 8-K, Regulation FD Disclosure May 09 2016
Owens & Minor Announces Second Quarter 2016 Cash Dividend of $0.255 per Share May 05 2016
Owens & Minor Announces Second Quarter 2016 Cash Dividend of $0.255 per Share May 05 2016
Owens & Minor, Inc. :OMI-US: Earnings Analysis: Q1, 2016 By the Numbers May 05 2016
Edited Transcript of OMI earnings conference call or presentation 4-May-16 12:30pm GMT May 04 2016
OWENS & MINOR INC/VA/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 04 2016
Owens & Minor Reports 1st Quarter 2016 Financial Results May 03 2016
Owens & Minor Reports 1st Quarter 2016 Financial Results May 03 2016
Q1 2016 Owens & Minor Inc Earnings Release - After Market Close May 03 2016
Avoid the 2 Big Mistakes Small-Cap Investors Make Apr 28 2016
Cardinal Health wins Kaiser Permanente contract with focus on controlling supply costs Apr 28 2016
Owens & Minor, Inc. – Value Analysis (NYSE:OMI) : April 22, 2016 Apr 22 2016
Owens & Minor, Inc. breached its 50 day moving average in a Bearish Manner : OMI-US : April 21, 2016 Apr 21 2016
Owens & Minor downgraded by Robert W. Baird Apr 21 2016
Stocks Higher In Afternoon; VMware Pops On Earnings Apr 20 2016
Be Wary of These Five Tanking Stocks Today, Office Depot Among Them Apr 20 2016
Distribution Agreement between Owens & Minor and a Large National Healthcare Provider Customer Will... Apr 20 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)